Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia (CARAN)
Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia in Gynecological Laparoscopic Surgeries
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210004
- Nanjing Maternal and Child Health Care Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA physical status I-II
- Chinese
- 19-45yr
- Selective laparoscopic surgeries
Exclusion Criteria:
- Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records
- Participants younger than 18 years, older than 45 years or pregnancy was eliminated
- Due to the significant changes in vital signs might affect cognition of pain and that of sensation, over 20% variation of these records from the baselines or below 92% of SpO2 under 20-40% nasal tube oxygen at any time should be excluded from the study
- Those who were not willing to or could not finish the whole study at any time
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: 1
Fentanyl delivered for controlling awaking pain
|
Fentanyl 0.5 μg/kg delivered intravenously immediate at the end of remifentanil pump finished
Other Names:
|
|
ACTIVE_COMPARATOR: 2
Sufentanil delivered for controlling awaking pain
|
Sufentanil 0.05 μg/kg delivered intravenously immediate at the end of remifentanil pump finished
Other Names:
|
|
ACTIVE_COMPARATOR: 3
Butorphanol delivered for controlling awaking pain
|
Butorphanol 0.01 mg/kg delivered intravenously immediate at the end of remifentanil pump finished
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
VAS ratings of pain
Time Frame: 0 min after awake from anesthesia; 5,10,15,20 and 30min after awake from anesthesia
|
0 min after awake from anesthesia; 5,10,15,20 and 30min after awake from anesthesia
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hemodynamics of patients
Time Frame: 30min before operation; every 10min during operation; 5,10,15,20,30 and 60min after operation
|
30min before operation; every 10min during operation; 5,10,15,20,30 and 60min after operation
|
|
Sedative ratings with VAS system
Time Frame: 0,5,10,15,25,45 and 60min after awake from anesthesia
|
0,5,10,15,25,45 and 60min after awake from anesthesia
|
|
Overall VAS satisfaction ratings
Time Frame: 1 h after operation
|
1 h after operation
|
|
Blood cortisol and β-endorphin levels
Time Frame: 0, 10min before the end of surgeries, 10min, 1h and 6h after operation
|
0, 10min before the end of surgeries, 10min, 1h and 6h after operation
|
|
Side effects
Time Frame: 1 h after operation
|
1 h after operation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pain, Postoperative
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Narcotic Antagonists
- Respiratory System Agents
- Anticoagulants
- Chelating Agents
- Sequestering Agents
- Antitussive Agents
- Calcium Chelating Agents
- Fentanyl
- Sufentanil
- Dsuvia
- Citric Acid
- Sodium Citrate
- Butorphanol
Other Study ID Numbers
Other Study ID Numbers
- NMU-FY2008-311
- NJFY0807311M
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.